Immunopathological characterization of selected mouse models of inflammatory bowel disease: Comparison to human disease  Yava L. Jones-Hall, Matthew B.

Slides:



Advertisements
Similar presentations
GASTRITIS ULCER DISEASE
Advertisements

Inflammatory Bowel Disease (IBD)
SMALL INTESTINE Practical II Pathology Dept, KSU GIT Block.
Inflammation p.1 SYLLABUS: Robbins and Cotran, Pathologic Basis of Disease, Chapter: Acute and Chronic Inflammation (all)
Gastrointestinal system SYLLABUS: RBP(Robbins Basic Pathology) Chapter: The Oral Cavity and the Gastrointestinal Tract.
Crohn's disease, terminal ileum, G
Immunopathological characterization of selected mouse models of inflammatory bowel disease: Comparison to human disease Yava L. Jones-Hall, Matthew B.
Typhoid Fever and Acute Appendicitis: A Rare Association Not Yet Fully Formed - DOI: / Fig. 1. H&E staining postlaparoscopic appendectomy.
Inflammatory Bowel Disease (IBD)
Volume 24, Issue 3, Pages (September 2017)
Upper panel shows a biopsy sample obtained from a normal volunteer and stained with periodic acid–Schiff (PAS) stain. The glycoprotein-rich epithelial.
Pleomorphic adenoma –the tumour at the left side is white gray firm lobulated mass without hemorrhage or necrosis. note the normal lobulated gland at the.
Uncovering Pathogenic Mechanisms of Inflammatory Bowel Disease Using Mouse Models of Crohn’s Disease–Like Ileitis: What is the Right Model?  Fabio Cominelli,
Nodular swelling of the tongue
GIT BLOCK PATHOLOGY PRACTICAL Dr Abdullah Basabein
Volume 114, Issue 4, Pages (April 1998)
Filiform polyposis associated with sigmoid diverticulitis in a patient without inflammatory bowel disease  Hyun-Soo Kim, Kil Yeon Lee, Youn Wha Kim  Journal.
Volume 115, Issue 3, Pages (September 1998)
Representative hematoxylin-eosin stained (HE) sections demonstrating immune checkpoint inhibition-related colitis representative HE sections demonstrating.
Volume 24, Issue 3, Pages (September 2017)
Y. Huang, X.-F. Tian, X.-G. Fan, C.-Y. Fu, C. Zhu 
Volume 122, Issue 5, Pages (May 2002)
Volume 133, Issue 4, Pages (October 2007)
Ghazaleh Aram, Theodore M. Bayless, Zong–Ming Chen, Elizabeth A
Carcinogenesis of Helicobacter pylori
Anti–tumor necrosis factor monoclonal antibody therapy for gastrointestinal Behçet's disease: A case report  Philip V. Hassard, Scott W. Binder, Viera.
Histological features of murine DSS-induced colitis.
Was It the Zebu? The American Journal of Medicine
Diverticular Disease–Associated Segmental Colitis
Volume 129, Issue 1, Pages (July 2005)
Volume 141, Issue 5, Pages (November 2011)
Case Rep Gastroenterol 2014;8: DOI: /
Volume 137, Issue 5, Pages (November 2009)
Malabsorption Work-up: Utility of Small Bowel Biopsy
Role of serotonin and nuclear factor-kappa B in the ameliorative effect of ginger on acetic acid-induced colitis  Eman S.H. Abd Allah, Rania Makboul,
Adult Autoimmune Enteropathy: Mayo Clinic Rochester Experience
Herpes Simplex Infection Causing Acute Necrotizing Tonsillitis
Volume 115, Issue 4, Pages (October 1998)
Asthma therapy and airway remodeling
Volume 132, Issue 3, Pages (March 2007)
The emerging role of histologic disease activity assessment in ulcerative colitis  Rish K. Pai, MD, PhD, Vipul Jairath, MD, PhD, Niels Vande Casteele,
This month in Gastroenterology
Pathophysiology of severe asthma
Volume 114, Issue 4, Pages (April 1998)
Volume 10, Issue 3, Pages (March 1999)
Ian R. Gooding, Roger Springall, Ian C. Talbot, David B.A. Silk 
Natural history of renal scarring in susceptible mIL-8Rh-/- mice
Shehzad Huda, Shabnum Chaudhery, Hassan Ibrahim, Arun Pramanik 
Beyond Standard Image-enhanced Endoscopy Confocal Endomicroscopy
Volume 132, Issue 5, Pages (May 2007)
Marta Wlodarska, Aleksandar D. Kostic, Ramnik J. Xavier 
Nodular Lymphoid Hyperplasia of the Lung: A Very Rare Disease Entity
Rapid development of colitis in NSAID-treated IL-10–deficient mice
Volume 125, Issue 6, Pages (December 2003)
Volume 120, Issue 4, Pages (March 2001)
Diagnosis of Colitis: Making the Initial Diagnosis
Novel biodegradable polydioxanone stents in a rabbit airway model
Volume 32, Issue 3, Pages (March 2010)
Lymphomatoid Granulomatosis: Past, Present,…Future?
Volume 129, Issue 1, Pages (July 2005)
Michael A. Ricci, MD, Gail Strindberg, MD, Jeffery M
Blockade of poly(ADP-ribose) synthetase inhibits neutrophil recruitment, oxidant generation, and mucosal injury in murine colitis  Basilia Zingarelli,
Volume 128, Issue 4, Pages (April 2005)
Ischemic colitis during treatment with alosetron
Volume 114, Issue 4, Pages (April 1998)
Inflammatory bowel disease and Ulcerative colitis
Human saphenous vein allograft bypass grafts: Immune response
Volume 124, Issue 4, Pages (April 2003)
Volume 10, Issue 3, Pages (March 1999)
Hypersensitivity pneumonia: UIP/IPF histopathologic presentation
Presentation transcript:

Immunopathological characterization of selected mouse models of inflammatory bowel disease: Comparison to human disease  Yava L. Jones-Hall, Matthew B. Grisham  Pathophysiology  Volume 21, Issue 4, Pages 267-288 (November 2014) DOI: 10.1016/j.pathophys.2014.05.002 Copyright © 2014 Elsevier B.V. Terms and Conditions

Fig. 1 Colon; IL10−/− mouse. The colon from 3-month-old mouse shows glandular elongation and distortion with mixed inflammation in the glandular lumens, lamina propria, and submucosa. Lymphocytes predominate, occasionally forming mucosal follicles. Hematoxylin and eosin (H&E) staining. Pathophysiology 2014 21, 267-288DOI: (10.1016/j.pathophys.2014.05.002) Copyright © 2014 Elsevier B.V. Terms and Conditions

Fig. 2 Colon; IL10−/− mouse. The colon from a 6-month-old mouse shows a large polyp with disordered and distended glands, goblet cell hyperplasia and marked, mixed inflammation in the mucosa and submucosa. Lymphoid follicles are also seen in the lamina propria. H&E staining. Pathophysiology 2014 21, 267-288DOI: (10.1016/j.pathophys.2014.05.002) Copyright © 2014 Elsevier B.V. Terms and Conditions

Fig. 3 (A).Terminal Ileum; TNF+/+ mouse at 8 weeks. The villus height and inflammatory component are normal. H&E staining. (B). Terminal Ileum; TNFΔARE/ΔARE mouse at 7 weeks. The changes are similar to those seen in the heterozygote 24-week animal. Villi are blunted and distorted, with a marked inflammatory infiltrate composed of lymphocytes, plasma cells, scattered neutrophils, and collections of submucosal histiocytes forming rudimentary granulomata. H&E staining. Reproduced with permission. Pathophysiology 2014 21, 267-288DOI: (10.1016/j.pathophys.2014.05.002) Copyright © 2014 Elsevier B.V. Terms and Conditions

Fig. 4 Colon;. Rag1−/− mouse. This mouse was reconstituted with CD4+CD45RBlow T cells and shows no inflammation; normal goblet cells and intact epithelium; and strands of mucus on some epithelial cells. H&E staining. Pathophysiology 2014 21, 267-288DOI: (10.1016/j.pathophys.2014.05.002) Copyright © 2014 Elsevier B.V. Terms and Conditions

Fig. 5 Colon; Rag1−/− mouse. This mouse was reconstituted with CD4+CD45RBhigh cells and has bowel wall thickening; transmural inflammation; loss of goblet cells; crypt abscesses; and epithelial erosion. H&E staining. Pathophysiology 2014 21, 267-288DOI: (10.1016/j.pathophys.2014.05.002) Copyright © 2014 Elsevier B.V. Terms and Conditions

Fig. 6 Colon; Samp1/YitFc mouse. 10-week-old mouse ileum showed segmental inflammatory disease with loss of normal villous architecture and expansion of the lamina propria with inflammatory cells (neutrophils, lymphocytes, macrophages, and plasma cells) within areas of inflammation. The inflammatory changes are most severe in the distal portion of the ileum (center of roll) and are accompanied by thickening of the muscular wall. H&E staining. Reproduced with permission. Pathophysiology 2014 21, 267-288DOI: (10.1016/j.pathophys.2014.05.002) Copyright © 2014 Elsevier B.V. Terms and Conditions

Fig. 7 Colon; Samp1/YitFc mouse. Higher magnification of the previous colon showing inflammation in the lamina propria and distortion of the epithelial architecture. H&E staining. Reproduced with permission. Pathophysiology 2014 21, 267-288DOI: (10.1016/j.pathophys.2014.05.002) Copyright © 2014 Elsevier B.V. Terms and Conditions

Fig. 8 Colon; B6 mouse. This mouse was exposed to 5% DSS for 5 days. The colon is multifocally eroded with patchy areas of epithelial regeneration. There is diffuse loss of glandular architecture with mixed inflammation and necrosis in the lamina propria. The submucosa is expanded by mild edema and mixed inflammation. H&E staining. Pathophysiology 2014 21, 267-288DOI: (10.1016/j.pathophys.2014.05.002) Copyright © 2014 Elsevier B.V. Terms and Conditions

Fig. 9 Colon; SV129-Smad3tm1Par/J. This mouse was chronically exposed to 3% DSS. The mucosa is markedly expanded by glandular hyperplasia and mixed inflammation. Glands are disorderly arranged, have a loss of goblet cells and are often distended by cell debris (abscess). The surface is eroded and replaced by mixed inflammation and markedly hyperplastic. There is submucosal gland herniation and marked submucosal inflammation. Herniated glands are distended by mucous and cell debris. H&E staining. Pathophysiology 2014 21, 267-288DOI: (10.1016/j.pathophys.2014.05.002) Copyright © 2014 Elsevier B.V. Terms and Conditions

Fig. 10 Colon; SV129 mouse. This mouse was sensitized via skin painting followed by one IR injection of EtOH. The mouse was euthanized 3 days after IR injection. The colon shows mild, mononuclear inflammation that is confined to the mucosa. There is no erosion or loss of goblet cells. Glandular architecture is essentially normal. H&E staining. Pathophysiology 2014 21, 267-288DOI: (10.1016/j.pathophys.2014.05.002) Copyright © 2014 Elsevier B.V. Terms and Conditions

Fig. 11 Colon; SV129 mouse. This mouse was sensitized via skin painting followed by one IR injection of TNBS/EtOH. The mouse was euthanized 3 days after IR injection. There is loss of gland with replacement by necrotic debris and mixed inflammation. The remaining glands have loss of goblet cells. There is mild expansion of the submucosa by edema and inflammation. H&E staining. Pathophysiology 2014 21, 267-288DOI: (10.1016/j.pathophys.2014.05.002) Copyright © 2014 Elsevier B.V. Terms and Conditions